RAVANI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.182
AS - Asia 2.312
EU - Europa 1.345
SA - Sud America 304
AF - Africa 35
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.183
Nazione #
US - Stati Uniti d'America 4.104
SG - Singapore 945
CN - Cina 577
IT - Italia 270
UA - Ucraina 244
BR - Brasile 238
VN - Vietnam 229
PL - Polonia 172
DE - Germania 171
HK - Hong Kong 170
GB - Regno Unito 135
TR - Turchia 128
FI - Finlandia 100
FR - Francia 69
JP - Giappone 66
IN - India 62
RU - Federazione Russa 54
MX - Messico 35
SE - Svezia 33
CA - Canada 32
BD - Bangladesh 26
IQ - Iraq 26
AR - Argentina 17
NL - Olanda 17
ZA - Sudafrica 17
BE - Belgio 15
CO - Colombia 14
EC - Ecuador 13
AT - Austria 11
ES - Italia 9
ID - Indonesia 9
PK - Pakistan 9
RO - Romania 7
CL - Cile 6
IE - Irlanda 6
LT - Lituania 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
JO - Giordania 5
MY - Malesia 5
PH - Filippine 5
VE - Venezuela 5
KE - Kenya 4
KW - Kuwait 4
PA - Panama 4
AU - Australia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KR - Corea 3
MA - Marocco 3
PE - Perù 3
PY - Paraguay 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BF - Burkina Faso 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NP - Nepal 1
SR - Suriname 1
Totale 8.183
Città #
Singapore 531
Ashburn 454
Woodbridge 366
Houston 301
Fairfield 292
Jacksonville 283
San Jose 235
Santa Clara 234
Chandler 230
Beijing 193
Ann Arbor 174
Warsaw 170
Hong Kong 164
Seattle 108
Wilmington 103
Cambridge 99
Izmir 82
Nanjing 79
Ho Chi Minh City 74
Los Angeles 71
Hanoi 65
Tokyo 62
Dallas 59
New York 57
Princeton 56
Ferrara 55
Boardman 48
Lauterbourg 42
Helsinki 36
Shanghai 35
Munich 33
Dearborn 31
São Paulo 27
Orem 25
Mexico City 24
Buffalo 23
San Diego 23
Shenyang 23
Jiaxing 19
Milan 19
Moscow 18
Changsha 17
Nanchang 17
Montreal 16
Manchester 15
Chennai 14
Brussels 13
Frankfurt am Main 13
Haiphong 13
Stockholm 13
Brooklyn 12
Council Bluffs 12
Hebei 12
London 12
Poplar 12
Boston 11
Denver 11
Ankara 10
Chicago 10
Hefei 10
Johannesburg 10
Rio de Janeiro 10
Turku 10
Jinan 9
Mountain View 9
Naples 9
Orange 9
Vienna 9
Atlanta 8
Auburn Hills 8
Basra 8
Bremen 8
Columbus 8
Da Nang 8
Indiana 8
Kunming 8
The Dalles 8
Baghdad 7
Bogotá 7
Bologna 7
Curitiba 7
Jakarta 7
Redwood City 7
Tianjin 7
Charlotte 6
Guangzhou 6
Pune 6
San Francisco 6
Cagliari 5
Centro 5
Dublin 5
Falkenstein 5
Falls Church 5
Hải Dương 5
Mumbai 5
Ningbo 5
Padova 5
Rome 5
Toronto 5
Zhengzhou 5
Totale 5.546
Nome #
Biodistribution of nanostructured lipid carriers: a tomographic study 325
FOCUS ON NANOSTRUCTURED LIPID CARRIERS AND MONOOLEIN AQUEOUS DISPERSIONS 305
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 285
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 264
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 230
Cationic lipid nanosystems as carriers for nucleic acids 228
Analysis of the drug release profiles from formulations based on micro and nano systems 227
Clotrimazole Nanoparticle gel for mucosal administration. 216
Budesonide microparticles for the treatment of Crohn's disease 199
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 195
Cationic lipid nanosystems as carriers for nucleic acids 194
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 193
Gelified reverse micellar dispersions as percutaneous formulations 189
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 183
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 182
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 181
Nanosistemi lipidici per la veicolazione di acidi nucleici 179
Eudragit® microparticles for the release of budesonide: A comparative study 177
Curcumin containing monoolein aqueous dispersions: a preformulative study 173
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 169
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 169
Cationic phosphines for the obtaining of non-viral vectors 163
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 162
Colloidal dispersions for the delivery of acyclovir: A comparative study 155
Liposomes- and ethosomes-associated distamycins: a comparative study 151
Evaluation of percutaneous absorption of naproxen from different liposomal formulations 149
Development of polymethacrylic/poloxamer microparticles for topical administration of biotech drugs 149
Waste material of propolis as a film forming agent intended to modify the metronidazole release: preparation and characterization 148
Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity. 141
Ethosomes for the delivery of anti-herpetic molecules 127
Eudragit/Pluronic microparticles for topical administration of peptides and proteins 123
Long-chain cationic derivatives of 1,3,5-triaza-7-phosphaadamantane as a tool to obtain new non-viral vectors 122
Long-chain cationic derivatives of PTA (1,3,5-triaza-7- phosphaadamantane) based SLN as new potential non-viral vectors 120
In vivo evaluation of nanostructured lipid labelled with 99mTc 117
Liposomal formulations for percutaneous absorption of naproxen: a comparative study 113
Semisolid formulations based on MAD or NLC for mucosal administration of Clotrimazole 113
Semisolid formulations based on nanostructured lipid carrier (NLC) for vaginal administration of clotrimazole 113
null 109
Niosomes containing HSV immunogens as possible vaccine against genital herpes 108
WO3 Colloids Characterized through SdFFF and FlFFF. 108
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 107
Macromolecular carriers to enhance distamycins’ activity 100
Eudragit/Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 99
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 98
New strategies for a vaginal delivery of clotrimazole 97
Preparation and characterization of microparticles containing budesonide 97
Nanoparticulate lipidic dispersions for bromocriptine delivery 96
Preformulative study of monoleinaqueous dispersions as drug delivery system for curcumin 95
SLN-containing cationic phospnines as potential non-viral vectors 95
Preparation and characterization by differential scanning calorimetry of l-dopa prodrug loaded solid lipid nanoparticles 95
Niosomi contenenti molecole biotecnologiche ad attivita’ antierpetica somministrati per via nasale 86
null 83
In vitro transport studies across rabbit nasal mucosa of a model compound intended for nose-to-brain delivery in post-traumatic stress disorder 60
null 51
null 45
Totale 8.258
Categoria #
all - tutte 33.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021215 0 0 0 0 0 0 0 0 0 116 67 32
2021/2022480 31 59 32 6 5 14 28 37 14 50 47 157
2022/2023549 58 26 23 61 93 90 11 55 76 2 31 23
2023/2024241 33 25 2 6 14 40 27 30 5 3 6 50
2024/20251.257 30 19 95 59 176 179 31 57 219 91 178 123
2025/20262.774 271 94 222 374 457 207 398 182 294 275 0 0
Totale 8.258